Market capitalization: > 1 Billion
Price/Earnings Ratio: > 0 < 100
Dividend Yield: > 3 < 20
Return on investment: > 10 < 100
Operating Margin: > 10 < 100
10 Year Revenue Growth: > 8 < 200
10 Year EPS Growth: > 10 < 100
Here are my most promising stocks from the list:
Vale (NYSE:VALE) has a market capitalization of $93.22 billion. The company employs 70,785 people, generates revenue of $58,990.00 million and has a net income of $21,517.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $34,234.00 million. The EBITDA margin is 58.03 percent (operating margin 51.05 percent and net profit margin 36.48 percent).
Financial Analysis: The total debt represents 19.04 percent of the company’s assets and the total debt in relation to the equity amounts to 31.53 percent. Due to the financial situation, a return on equity of 30.99 percent was realized. Twelve trailing months earnings per share reached a value of $3.07. Last fiscal year, the company paid $1.73 in form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 5.89, P/S ratio 1.66 and P/B ratio 1.20. Dividend Yield: 6.31 percent. The beta ratio is 1.57.
Long-Term Stock History Chart Of Vale SA (ADR) (Click to enlarge) |
Long-Term Dividends History of Vale SA (ADR) (VALE) (Click to enlarge) |
Long-Term Dividend Yield History of Vale SA (ADR) (NYSE: VALE) (Click to enlarge) |
Companhia de Bebida Das Americas (NYSE:ABV) has a market capitalization of $122.58 billion. The company employs 46,503 people, generates revenue of $13,300.66 million and has a net income of $4,275.46 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6,429.66 million. The EBITDA margin is 48.34 percent (operating margin 43.17 percent and net profit margin 32.14 percent).
Financial Analysis: The total debt represents 8.92 percent of the company’s assets and the total debt in relation to the equity amounts to 16.07 percent. Due to the financial situation, a return on equity of 34.58 percent was realized. Twelve trailing months earnings per share reached a value of $1.40. Last fiscal year, the company paid $0.90 in form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 28.17, P/S ratio 8.27 and P/B ratio 9.77. Dividend Yield: 3.54 percent. The beta ratio is 0.96.
Long-Term Stock History Chart Of Companhia de Bebi... (Click to enlarge) |
Long-Term Dividends History of Companhia de Bebi... (ABV) (Click to enlarge) |
Long-Term Dividend Yield History of Companhia de Bebi... (NYSE: ABV) (Click to enlarge) |
General Dynamics (NYSE:GD) has a market capitalization of $22.42 billion. The company employs 89,800 people, generates revenue of $32,677.00 million and has a net income of $2,552.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $4,418.00 million. The EBITDA margin is 13.52 percent (operating margin 11.71 percent and net profit margin 7.81 percent).
Financial Analysis: The total debt represents 11.27 percent of the company’s assets and the total debt in relation to the equity amounts to 29.70 percent. Due to the financial situation, a return on equity of 19.23 percent was realized. Twelve trailing months earnings per share reached a value of $6.85. Last fiscal year, the company paid $1.88 in form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 9.27, P/S ratio 0.70 and P/B ratio 1.71. Dividend Yield: 3.21 percent. The beta ratio is 1.25.
Long-Term Stock History Chart Of General Dynamics ... (Click to enlarge) |
Long-Term Dividends History of General Dynamics ... (GD) (Click to enlarge) |
Long-Term Dividend Yield History of General Dynamics ... (NYSE: GD) (Click to enlarge) |
Abbott Laboratories (NYSE:ABT) has a market capitalization of $104.65 billion. The company employs 91,000 people, generates revenue of $38,851.26 million and has a net income of $4,728.45 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,795.84 million. The EBITDA margin is 22.64 percent (operating margin 14.81 percent and net profit margin 12.17 percent).
Financial Analysis: The total debt represents 25.57 percent of the company’s assets and the total debt in relation to the equity amounts to 63.07 percent. Due to the financial situation, a return on equity of 20.07 percent was realized. Twelve trailing months earnings per share reached a value of $3.09. Last fiscal year, the company paid $1.92 in form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 21.54, P/S ratio 2.70 and P/B ratio 4.28. Dividend Yield: 3.06 percent. The beta ratio is 0.31.
Long-Term Stock History Chart Of Abbott Laboratories (Click to enlarge) |
Long-Term Dividends History of Abbott Laboratories (ABT) (Click to enlarge) |
Long-Term Dividend Yield History of Abbott Laboratories (NYSE: ABT) (Click to enlarge) |
Take a closer
look at the full table of best dividend paying stocks as of August 2012. The average price to earnings ratio (P/E ratio) amounts
to 12.41 while the dividend yield has a value of 5.56 percent. Price to book
ratio is 3.09 and price to sales ratio 3.08. The operating margin amounts to 32.54
percent. Earnings per share grew by 19.20 yearly over the past decade.
Related Stock Ticker Symbols:
Best Dividend Paying Stock List (Click to enlarge) |
YPF, MFA, BPT,
SID, ARLP, VALE, SCCO, YZC, HEP, PBR, MMP, MBT, GRMN, SSL, STO, NVS, MCHP, BBL,
CHL, ABV, TLK, CEO, GNTX, BHP, STX, CVX, GD, RIO, LLTC, ABT
Selected Articles: